SHAWNA DELLAY: Open Payments
NPI 1710386214 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 66 payments from 19 companies in 2025. Trend: 2023 $325 · 2024 $609 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $203 |
| PFIZER INC. | 4 | $80 |
| Axsome Therapeutics, Inc. | 4 | $77 |
| Alkermes, Inc. | 4 | $67 |
| Novo Nordisk Inc | 2 | $33 |
| Lundbeck LLC | 2 | $32 |
| Indivior Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: CAPLYTA, VRAYLAR, Auvelity, ARISTADA, MAVYRET, NURTEC ODT, REXULTI, QULIPTA.
Industry payments across IN — which companies pay providers there.
